🔗 Share this article

An underground market for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Drug Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these profiles directly for supplier links, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a robust market exists on messaging services, where groups with numerous of participants share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers market the drug there before directing customers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Express Concerns

However, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the UK is worrisome and could result in users injecting products of uncertain source.

Several professionals said the demand for the experimental drug could be connected to the rising cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for human use under the British medical regulations.

Several content creators try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate medicines, advertising, and customer regulations, potentially leading to penalties, legal action or prison.

Platform Reaction and Content Removal

Based on the social media company, the service has taken down violative content and banned associated hashtags and query recommendations. The company said it was committed to keeping the platform safe and allocating resources in enhancing compliance measures.

Digital Trading Operations

Investigations also found groups with up to nine thousand members marketing the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays channels with numerous of users, filled with photos of slimming results, glowing reviews and step-by-step instructions for preparing or injecting at residence.

Within minutes of entering one community, a vendor posted contact information, where most transactions take place. The vendor sent an guidebook and guaranteed shipping within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None asked about weight, medical conditions or previous experience.

Item Details and Costs

Inside these communities, posts display dark colored parcels with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled pens usually sold at 160 pounds for 20 milligrams. When asked how long a pen should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for Telegram stated it actively monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting materials they can’t verify. Even if the science behind this drug is valid, these online products may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in interest to current price rises for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are using social media. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has previously seen patients injured by personal administration from unverified sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a company experimental product not yet authorized … may expose users to possibly serious medical dangers”.